EDGAR Filing Documents for 0001193125-10-051371

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001193125-10-051371

Filing Date

2010-03-09

Accepted

2010-03-09 16:10:47

Documents

Period of Report

2009-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	d10k.htm	10-K	895992
2	VOLUME SUBMITTER DEFINED CONTRIBUTION PLAN	dex106.htm	EX-10.6	561817
3	ADOPTION AGREEMENT FOR 401(K) PLAN	dex107.htm	EX-10.7	515433
4	AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT	dex1021.htm	EX-10.21	22177
5	LEASE AMENDMENT DATED 01/22/2010	dex1025.htm	EX-10.25	39436
6	LIST OF SUBSIDIARIES OF THE REGISTRANT	dex211.htm	EX-21.1	2033
7	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM	dex231.htm	EX-23.1	1868
8	CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)	dex311.htm	EX-31.1	7056
9	CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)	dex312.htm	EX-31.2	7107
10	CERTIFICATION OF CEO PURSUANT TO 18 USC SECTION 1350	dex321.htm	EX-32.1	3874
11	CERTIFICATION OF CFO PURSUANT TO 18 USC SECTION 1350	dex322.htm	EX-32.2	4035
	Complete submission text file	0001193125-10-051371.txt		2062230

Mailing Address 3911 SORRENTO VALLEY BLVD SAN DIEGO CA 92121

Business Address 3911 SORRENTO VALLEY BLVD SAN DIEGO CA 92121 858-558-2871

ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)